CRAMS capabilities

CRAMS (Contract Research and Manufacturing Services)


YES Pharma has emerged as a preferred outsourcing partner for leading global pharmaceutical & life science companies. We have the required capability to deliver products and services across the pharmaceutical value chain. To make our business model truly comprehensive, we have embarked upon Contract/Custom Research and Manufacturing Services (CRAMS). We have been successfully deploying our capabilities and our contract partners' developed IP for cooperation manufacturing.

We position ourselves centrally in the drug discovery domain with the right mix of infrastructure, knowledge and business orientation. With CRAMS, we also reinforce our position as a preferred global partner with the potential to undertake a wide range of projects on a 'FTE' or 'fee for service' basis from molecule scale up till full scale cGMP commercial production.

Our service value proposition includes:

  • Offering dedicated teams and manufacturing lines up till full scale cGMP commercial production
  • Leveraging resident drug discovery experience in multi-therapeutic and multi-lead discovery programs
  • Providing business flexibility with early phase to proof-of-concept collaboration, enabling contract research and development projects across multiple domains
  • Scaling chemical development to a technologically efficient and cost-effective manner through the intelligent use of process optimization and CMC (chemistry, manufacturing and controls) skills
  • Investing ethical values in our business activities, reflected in important knowledge protection initiatives and building walls to teams working for partner companies and protecting intellectual property
  • Manufacturing lab-scale, pre-clinical and clinical scale supplies at our approved partner sites
  • Broad range of technical skills and capabilities encompassing all routine chemistries and a wide variety of sophisticated modern technologies

YES Pharma is committed to be a customer focused innovative organization providing our customers with enhanced value through partnerships in discovery, research, development, commercialization, and integrated supply chain for the global pharmaceutical markets

Dun and Bradstreet